2025年Prurigo nodularis:当前和新兴的治疗方法
Sarah G Brooks1, Gil Yosipovitch1
1Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
Clinics in dermatology
|March 19, 2025
概括
结 (prurigo nodularis,简称PN) 是一种慢性皮肤疾病,导致严重的. 最近的进展,包括dupilumab,为管理这种衰弱的疾病提供了新的希望.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 结膜炎 (PN) 是一种慢性炎症性皮肤疾病,引起患者严重的痛苦和有限的治疗选择.
- 从历史上看,对PN病变的理解是有限的,这阻碍了有效的治疗开发.
研究的目的:
- 审查目前和新兴的治疗方法用于prurigo nodularis.
- 解决影响PN有效治疗的挑战.
主要方法:
- 对目前和新兴治疗prurigo nodularis的文献综述.
- 对理解PN病变发生的进展进行分析.
主要成果:
- 杜皮卢马布 (Dupilumab) 针对4号和13号互白蛋白,是FDA批准的第一个用于中度至重度PN的生物药物,彻底改变了患者管理.
- 几种新疗法正在开发中,显示出更广泛可用性的承诺.
结论:
- 在了解PN方面取得了重大进展,这导致了新的治疗选择.
- 尽管取得了进展,但在有效治疗prurigo nodularis方面仍然存在挑战.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


